Table 1 Main characteristics of the included studies in the meta-analysis
From: Association between the APOB XbaI and EcoRI polymorphisms and lipids in Chinese: a meta-analysis
First author,year | Ethnicity | Region | Sample size | SNPs | Character of subjects | Method | Lipid profile |
|---|---|---|---|---|---|---|---|
Bai, [15]2008 | Han | Ningxia | 165 | EcoRI | CA/HT | PCR-RFLP | TC,TG,LDL,HDL |
Chai, [16] 1996 | Han | Shanghai | 82 | XbaI | CI/HT | PCR-RFLP | TC,TG,LDL,HDL |
Evans, [17] 1993 | Han | Shanxi | 143 | XbaI | HT | PCR-RFLP | TG,LDL,HDL |
Fan, [18] 2009 | Han | Fujian | 387 | XbaI | Hyperlipidemia | PCR-RFLP | TC,TG,LDL,HDL |
Guo, [19] 1996 | Han | Liaoning | 55 | XbaI | CI | PCR-RFLP | TC,TG,LDL,HDL |
Han, [20] 2000 | Han | Shanghai | 631 | XbaI | Cholelithiasis/HT | PCR-RFLP | TC,TG,LDL,HDL |
Hu, [21] 2008 | Han | Guangxi | 150 | XbaI | PNS | PCR-RFLP | TC,TG,LDL,HDL |
Hu, [13] 2009 | Han | Guangxi | 200 | XbaI | HT | PCR-RFLP | TC,TG,LDL,HDL |
Ji,[22] 2014 | Han | Inner mongolian | 120 | EcoRI,XbaI | Cholelithiasis/HT | PCR-RFLP | TC,TG,LDL,HDL |
Li, [23] 1997 | Han | Tianjing | 71 | EcoRI,XbaI | CHD | PCR-RFLP | TC,TG,LDL,HDL |
Liu, [24] 2008 | Han | Hunan | 230 | EcoRI | CI/HT | PCR-RFLP | TC,TG,LDL,HDL |
Liu, [25] 2010 | Han | Shanghai | 186 | XbaI | Gastric cancer | PCR-RFLP | TC,LDL |
Liu,[26] 2014 | Li/Han | Hainan | 351 | XbaI | HT | PCR-RFLP | TC,TG,LDL,HDL |
Ma, [27] 2012 | Yao | Guangdong | 500 | EcoRI,XbaI | Hyperlipidemia/HT | PCR-RFLP | TC,TG,LDL,HDL |
Pan, [28] 1995 | Han | Taiwan | 301 | EcoRI,XbaI | CHD/HT | PCR-RFLP | TC,TG,LDL,HDL |
Saha, [29] 1992 | Han | Singapore | 196 | EcoRI,XbaI | HT | PCR-RFLP | TC,TG,LDL,HDL |
Tan, [30] 2003 | Han | Jiangsu | 211 | EcoRI,XbaI | Cholelithiasis/HT | PCR-RFLP | TC,TG,LDL,HDL |
Wang, [31] 1999 | Han | Beijing | 377 | XbaI | CI/HT | PCR-RFLP | TC,TG,LDL,HDL |
Wei, [32] 2001 | Han | Sichuan | 169 | XbaI | Cholelithiasis/HT | PCR-RFLP | TC,TG,LDL,HDL |
Xie, [33] 2010 | Han | Xinjiang | 300 | EcoRI,XbaI | Hyperlipidemia/HT | PCR-RFLP | TC,TG,LDL,HDL |
Yan, [34] 2003 | Han | Beijing | 257 | EcoRI | CHD/HT | PCR-RFLP | TC,TG,LDL,HDL |
Yao, [14] 1999 | Han | Jiangsu | 141 | XbaI | CI/HT | PCR-RFLP | TC,TG,LDL,HDL |
Yao, [35] 2005 | Han | Xinjiang | 112 | EcoRI,XbaI | fatty liver | DNA chips | TC,TG,LDL,HDL |
Ye, [36] 1995 | Han | Beijing | 203 | XbaI | CHD/HT | PCR-RFLP | TC,TG,LDL,HDL |
Ye, [37] 2003 | Han | Beijing | 88 | XbaI | Hyperlipidemia | PCR-RFLP | TC,TG,LDL |
Zhang, [39] 2009 | Han | Hunan | 130 | XbaI | CI | PCR-RFLP | TC,TG,LDL,HDL |
Zhang,[38] 2010 | Han | Xinjiang | 154 | EcoRI | CHD | PCR-RFLP | TC,TG,LDL,HDL |
Zhang, [40] 2015 | Han | Beijing | 82 | EcoRI,XbaI | Hyperlipidemia | PCR-RFLP | TC,TG,LDL,HDL |
Zhao, [41] 1997 | Han | Beijing | 117 | XbaI | CI | PCR-RFLP | TC,TG,LDL,HDL |
Zhu, [42] 2001 | Han | Beijing | 308 | XbaI | HT | PCR-RFLP | TC,TG,LDL,HDL |